You have 9 free searches left this month | for more free features.

tocilizumab

Showing 26 - 50 of 243

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19 Trial in New York (Tocilizumab)

Active, not recruiting
  • COVID-19
  • Tocilizumab
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Covid19 Trial in Ipatinga, Varginha, Aracaju (Tocilizumab, Heparin - Therapeutic dosage, Heparin - Prophylactic dosage)

Completed
  • Covid19
  • Tocilizumab
  • +2 more
  • Ipatinga, Minas Gerais, Brazil
  • +2 more
Mar 17, 2022

COVID-19 Virus Infection, Cytokine Storm, Corticosteroid Trial (Methylprednisolone, Tocilizumab)

Withdrawn
  • COVID-19 Virus Infection
  • +3 more
  • (no location specified)
Nov 22, 2021

Melanoma Trial in Los Angeles, Boston, New York (Ipilimumab, Nivolumab, Tocilizumab)

Recruiting
  • Melanoma
  • Los Angeles, California
  • +3 more
Mar 29, 2022

Acute Myocardial Infarction, Cardiogenic Shock Trial in Copenhagen (Tocilizumab, Dobutamine, NaCl 0.9%)

Recruiting
  • Acute Myocardial Infarction
  • Cardiogenic Shock
  • Tocilizumab
  • +2 more
  • Copenhagen, Denmark
    Rigshospitalet, Copenhagen University Hospital
Apr 21, 2022

Rapid Progressive Interstitial Lung Diseases Trial in Beijing (Tocilizumab)

Recruiting
  • Rapid Progressive Interstitial Lung Diseases
  • Tocilizumab
  • Beijing, China
    Peking Union Medical College Hospital
Dec 19, 2021

Rheumatoid Arthritis Trial in China (Tocilizumab, MTX, Placebo Matched to MTX)

Completed
  • Rheumatoid Arthritis
  • Tocilizumab
  • +3 more
  • Baotou, China
  • +19 more
Dec 5, 2022

Multiple Myeloma Trial (Teclistamab, Tocilizumab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 24, 2023

Giant Cell Arteritis Trial in Basel, Bern (Tocilizumab)

Completed
  • Giant Cell Arteritis
  • Tocilizumab
  • Basel, Switzerland
  • +1 more
Nov 4, 2021

ive Alzheimer's Medicines (DREAM) - Tocilizumab vs Abatacept

Completed
  • Rheumatoid Arthritis
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 15, 2021

COVID-19 Trial in Worldwide (Tocilizumab)

Recruiting
  • COVID-19
  • Tocilizumab
  • Orange, California
  • +13 more
Aug 4, 2022

Hematologic Malignancy, Bone Marrow Transplant Trial in New York (Tocilizumab, Fludarabine, Melphalan)

Recruiting
  • Hematologic Malignancy
  • Bone Marrow Transplant
  • Tocilizumab
  • +4 more
  • New York, New York
    Weill Cornell Medical College
Oct 27, 2021

Tocilizumab on Procalcitonin and Other Biochemical and Clinical

Not yet recruiting
  • COVID-19 Pneumonia
  • ARDS
  • Tocilizumab
  • Imsida, Malta
    Mater Dei Hospital
Sep 2, 2021

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Boston, Massachusetts
  • +1 more
Sep 12, 2023

Antibody-mediated Rejection Trial in Gothenburg, Stockholm, Uppsala (Tocilizumab)

Recruiting
  • Antibody-mediated Rejection
  • Tocilizumab
  • Gothenburg, Vastra Gotaland Regioin, Sweden
  • +2 more
Feb 16, 2022

Schizophrenia, Psychotic Disorders Trial in Augusta (Tocilizumab, Normal saline)

Recruiting
  • Schizophrenia
  • Psychotic Disorders
  • Tocilizumab
  • Normal saline
  • Augusta, Georgia
    Augusta University
Jul 27, 2021

Acute Leukemia, Chronic Leukemia, Lymphoma Trial in Milwaukee (Nivolumab (.25 mg/kg), Tocilizumab, Nivolumab (.5 mg/kg))

Terminated
  • Acute Leukemia
  • +3 more
  • Nivolumab (.25 mg/kg)
  • +2 more
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Oct 4, 2021

Giant Cell Arteritis Trial in Boston (Tocilizumab, Prednisone)

Recruiting
  • Giant Cell Arteritis
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 23, 2021

Breast Cancer Trial in Chicago, Ann Arbor, New Haven (Trastuzumab, Pertuzumab, Tocilizumab)

Completed
  • Breast Cancer
  • Chicago, Illinois
  • +2 more
Sep 8, 2021

Schizophrenia Trial in Augusta (Tocilizumab)

Completed
  • Schizophrenia
  • Tocilizumab
  • Augusta, Georgia
    Georgia Health Sciences University
Jul 27, 2021

Relapsed or Refractory Multiple Myeloma Trial (Cevostamab, Elranatamab, Tocilizumab)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Jun 22, 2023

Systemic Lupus Erythematosus Trial (RO7507062, Tocilizumab)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • (no location specified)
Apr 19, 2023

Mantle Cell Lymphoma, Mantle Cell Lymphoma Refractory Trial (Glofitamab, Pirtobrutinib, Obinutuzumab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Mantle Cell Lymphoma Refractory
  • (no location specified)
Apr 18, 2023

SARS-CoV 2 Trial in Boston, Newton (Tocilizumab, Placebos)

Completed
  • SARS-CoV 2
  • Tocilizumab
  • Placebos
  • Boston, Massachusetts
  • +2 more
Jul 23, 2021

Tocilizumab, COVID-19, Critical Care Trial in Trabzon (Tocilizumab)

Completed
  • Tocilizumab
  • +3 more
  • Tocilizumab
  • Trabzon, Turkey
    Karadeniz Technical University
May 18, 2021